跳至主要内容
临床试验/ACTRN12619000275167
ACTRN12619000275167已完成4 期

The effect of Systane Complete versus saline on tear film properties in a symptomatic dry eye population

SW Sydney0 个研究点目标入组 39 人开始时间: 2019年2月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
  • Adults aged 18 years and over with symptoms of dry eye;
  • Ocular Surface Disease Index score of greater than 12 at Screening (Visit 1);
  • Average lipid layer thickness less than or equal to 75nm in at least one eye at Screening;
  • Not wearing contact lenses for 1 month prior to the study and for the duration of the study;
  • Willing to use the study eye drops and refrain from using any other eye drops for the duration of the study;
  • Willing to refrain from using the study eye drops within 4 hours prior to each study visit;
  • Willing to comply with the study visit schedule and adhere to instructions as directed by the Investigator.

排除标准

  • Any active anterior segment disease excluding blepharitis;
  • Use of any of the following medications (including steroids) up to 12 weeks prior to start of the study or during the course of the study:
  • Ocular medication, category S3 and above;
  • Any systemic or topical medications that will affect ocular physiology e.g. anti-acne medications such as Roaccutane and corticosteroid or immunosuppressant medications such as Hydrocortisone, Prednisolone and antihistamine medications such as Claritine.
  • Use of any polyunsaturated fatty acid-containing dietary supplements (such as fish oil, evening primrose oil, linseed oil) for less than 12 weeks prior to the start of the study;
  • Planned changes to intake of polyunsaturated fatty acid-containing dietary supplements and/or diet (including typical intake of fish) for the duration of the study;
  • Use of any at-home eyelid warming treatments for less than 12 weeks prior to the start of the study, or planned changes to routine usage over the course of the study;
  • Use of any of the following dry eye treatments up to 6 months prior to the start of the study or during the course of the study:
  • oIntense Pulsed Light (IPL) therapy;
  • oBlephasteam;
  • oLipiFlow Thermal Pulsation treatment;
  • oPunctal plugs.
  • Any systemic disease that may affect ocular health e.g. Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis and systemic lupus erythematosus;
  • History of eye surgery within 6 months prior to enrolment in the study;
  • Epilepsy or history of migraines exacerbated by flashing, strobe-like lights;
  • Any known allergy to the ingredients in Systane Complete;
  • Pregnancy or breastfeeding.

研究者

发起方
SW Sydney

相似试验